Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

**NM signifies a non meaningful value. A dash signifies the data is not available.

Beta Bionics is targeting a valuation of up to $695 million in an upsized initial public offering, the insulin delivery device maker said on Tuesday.

In trading on Tuesday, shares of Novo-Nordisk AS (Symbol: NVO) entered into oversold territory, hitting an RSI reading of 28.6, after changing hands as low as $81 per share. By comparison ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

“Novo Nordisk retains a sizable monopoly power on ... Meanwhile, Denmark has updated its royal coat of arms to feature prominent symbols of Greenland and the Faroe Islands in solidarity with ...

The King has warned of the dangerous re-emergence of antisemitism and met with Holocaust survivors on the 80th anniversary of ...

sharewise is a website that is operated by a small team in a part-time capacity. We will try to get back to you as soon as possible, but please understand that it might take a bit of time.

It hasn't been a great period for investors in Novo Nordisk (NYSE: NVO) despite its ongoing status as one of the pharmaceutical industry's apex competitors in the field of cardiometabolic drugs.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...